▁Chron 10.375
ic 5.49609375
▁pain 11.6953125
▁is 5.5546875
▁still 6.25390625
▁considered 5.03125
▁to 1.7314453125
▁be 0.4521484375
▁an 3.0078125
▁extr 8.4375
G 14.4765625
eme 10.0078125
▁issue 12.3984375
▁among 8.40625
▁at 7.41015625
▁least 2.482421875
▁ 2.865234375
8 3.71484375
% 6.14453125
▁of 1.6728515625
▁the 1.5439453125
▁residents 5.98046875
▁of 2.400390625
▁progress 10.15625
ive 0.95703125
▁countries 7.81640625
. 2.216796875
▁The 2.6328125
▁introduction 7.81640625
▁of 0.280029296875
▁the 1.6513671875
▁study 6.48046875
▁describes 7.98828125
▁the 0.8310546875
▁apparent 9.1953125
▁link 6.6875
▁between 0.485107421875
▁pain 6.640625
▁and 0.81005859375
▁dem 8.7109375
oral 3.5859375
ization 0.28857421875
. 1.501953125
▁Chron 5.32421875
ic 0.0277862548828125
▁pain 0.351318359375
▁is 1.26953125
▁always 6.5078125
▁accompanied 2.451171875
▁by 0.0367431640625
▁negative 4.86328125
▁emot 1.4365234375
ional 1.2353515625
▁experiences 2.916015625
▁and 2.138671875
▁blocks 11.0
▁a 4.15234375
▁person 1.564453125
’ 24.5625
s 2.763671875
▁ability 1.705078125
▁to 0.051513671875
▁receive 6.2890625
▁joy 4.953125
▁and 1.3828125
▁satisfaction 3.041015625
▁from 1.2314453125
▁life 1.0126953125
. 0.32666015625
▁The 1.931640625
▁research 4.03515625
▁investig 5.16015625
ates 0.47314453125
▁the 0.450927734375
▁development 5.8125
▁of 0.170166015625
▁de 4.09765625
pression 0.28173828125
▁and 1.27734375
▁anx 2.41796875
iety 0.00414276123046875
▁among 2.37890625
▁patients 2.3671875
▁receiving 4.53125
▁ph 6.58984375
arma 1.6826171875
ce 0.01202392578125
ut 0.000701904296875
ical 0.0096893310546875
▁op 5.7109375
io 0.1640625
ids 0.63330078125
▁and 2.35546875
▁medical 6.12109375
▁mar 2.19921875
iju 0.04351806640625
ana 0.00023937225341796875
▁( 4.34765625
MM 0.467041015625
) 3.05078125
▁as 2.8828125
▁severe 10.21875
▁pain 1.572265625
kill 3.390625
ers 0.0025539398193359375
. 0.53759765625
▁It 3.31640625
▁comp 5.328125
ares 0.05096435546875
▁the 0.62548828125
▁effic 6.40625
acy 0.007671356201171875
▁of 0.267822265625
▁pres 5.328125
cri 1.703125
ptions 0.6552734375
▁and 2.306640625
▁exam 6.05859375
ines 0.0129241943359375
▁the 0.447265625
▁possibility 3.671875
▁of 0.104736328125
▁post 7.08984375
- 0.80126953125
tre 2.609375
at 0.015411376953125
ment 0.0085601806640625
▁de 1.8779296875
pression 0.09814453125
. 1.755859375
<0x0A> 2.3984375
There 4.85546875
▁is 1.0302734375
▁currently 4.5234375
▁a 1.26953125
▁severe 5.0234375
▁lack 3.27734375
▁of 0.02264404296875
▁information 2.03515625
▁about 1.376953125
▁the 0.464599609375
▁effects 2.923828125
▁of 0.0728759765625
▁op 1.966796875
i 3.859375
ates 0.137939453125
. 3.85546875
▁They 4.89453125
▁manage 8.875
▁pain 3.25390625
▁successfully 5.8203125
, 1.0625
▁but 0.3232421875
▁the 2.677734375
▁past 9.484375
▁few 2.435546875
▁dec 0.859375
ades 8.237361907958984e-05
▁indicated 9.8515625
▁the 2.025390625
▁growing 4.69140625
▁concern 3.65234375
▁regarding 2.939453125
▁op 3.6953125
iate 0.740234375
▁ab 1.6083984375
use 0.00807952880859375
▁in 3.38671875
▁forms 10.546875
▁of 0.4521484375
▁over 3.30859375
d 0.338134765625
ose 0.1688232421875
▁and 0.69873046875
▁add 1.1044921875
iction 0.027984619140625
. 0.2213134765625
▁A 3.970703125
▁more 5.62109375
▁manage 9.0
able 0.004314422607421875
▁and 2.244140625
▁sa 2.205078125
fer 0.00011038780212402344
▁alternative 1.6923828125
▁might 6.53515625
▁be 0.17529296875
▁medical 2.712890625
▁mar 0.1888427734375
iju 0.004093170166015625
ana 0.0006742477416992188
. 1.5810546875
▁However 2.861328125
, 0.00691986083984375
▁the 1.6240234375
▁legal 4.26171875
▁status 1.1611328125
▁and 2.759765625
▁novel 9.2265625
ty 0.6962890625
▁of 0.19677734375
▁this 1.62890625
▁drug 2.064453125
▁do 4.94921875
▁not 0.0611572265625
▁allow 1.0078125
▁finding 8.8671875
▁a 2.3515625
▁large 4.265625
▁number 1.3603515625
▁of 0.004093170166015625
▁studies 1.3232421875
▁on 1.50390625
▁its 0.98388671875
▁effect 2.068359375
iveness 0.40869140625
. 0.990234375
▁Specifically 8.1171875
, 0.12158203125
▁it 2.6953125
▁concerns 4.796875
▁the 0.63720703125
▁emot 7.234375
ional 0.0170745849609375
▁condition 5.3515625
▁of 0.34033203125
▁patients 0.6953125
▁experien 6.33203125
cing 4.696846008300781e-05
▁chron 1.14453125
ic 0.002506256103515625
▁pain 0.0975341796875
. 0.6943359375
▁This 3.17578125
▁research 3.033203125
▁paper 6.26953125
▁a 2.1328125
ims 0.00035500526428222656
▁to 0.08245849609375
▁analyze 3.1171875
▁levels 9.4453125
▁of 0.0361328125
▁de 0.5751953125
pression 0.04119873046875
▁and 0.26025390625
▁anx 0.044097900390625
iety 0.0012302398681640625
▁among 0.80224609375
▁people 3.275390625
▁receiving 0.982421875
▁ther 7.74609375
apy 0.336181640625
▁by 5.19140625
▁comparing 8.03125
▁the 0.99072265625
▁effects 2.18359375
▁of 0.0305023193359375
▁ph 2.41015625
arma 0.04656982421875
ce 0.0013751983642578125
ut 9.1552734375e-05
ical 0.003925323486328125
▁op 0.3115234375
io 0.1832275390625
ids 0.059600830078125
▁and 0.280029296875
▁MM 1.2333984375
. 1.09375
<0x0A> 1.0537109375
The 1.353515625
▁study 2.013671875
▁was 2.01953125
▁conducted 0.75732421875
▁in 1.525390625
▁the 1.3740234375
▁form 2.1875
▁of 0.00714111328125
▁collection 10.0390625
▁and 1.724609375
▁analysis 0.68359375
▁of 0.049346923828125
▁statistical 4.15625
▁data 0.12322998046875
. 0.923828125
▁Part 4.8828125
icip 0.060302734375
ants 0.049774169921875
▁were 0.70166015625
▁rec 3.26953125
ru 0.0010557174682617188
ited 6.67572021484375e-05
▁for 4.0703125
▁six 7.50390625
▁months 0.48779296875
▁at 3.787109375
▁two 2.515625
▁major 5.45703125
▁pain 3.23828125
▁relief 5.296875
▁cent 1.5341796875
ers 0.074462890625
▁in 0.6982421875
▁Israel 4.45703125
. 0.46240234375
▁The 1.208984375
▁research 2.236328125
ers 1.5576171875
▁used 2.6953125
▁The 8.03125
▁De 4.1953125
pression 0.01447296142578125
▁Module 10.0703125
▁of 0.99365234375
▁the 0.315185546875
▁Pat 2.35546875
ient 0.007785797119140625
▁Health 0.08209228515625
▁Question 0.01464080810546875
naire 0.0185089111328125
▁and 3.373046875
▁the 0.69775390625
▁General 1.6591796875
ized 0.69921875
▁An 0.016357421875
x 0.00014674663543701172
iety 0.0027942657470703125
▁Dis 0.52001953125
order 0.03546142578125
▁Sc 1.1845703125
ale 0.07086181640625
▁to 1.8076171875
▁interview 7.1015625
▁participants 1.99609375
, 3.634765625
▁evaluate 5.65625
▁their 0.76220703125
▁answers 6.50390625
, 0.92431640625
▁and 0.1485595703125
▁conduct 4.45703125
▁the 2.33984375
▁study 2.318359375
. 0.23486328125
▁To 5.05859375
▁specifically 9.8984375
▁evaluate 2.52734375
▁and 4.3984375
▁compare 0.9658203125
▁the 0.32958984375
▁prob 11.2265625
abilities 0.2220458984375
▁of 0.1290283203125
▁de 0.818359375
pression 0.039093017578125
▁or 4.59375
▁anx 0.037322998046875
iety 0.0003180503845214844
▁among 1.736328125
▁the 2.26171875
▁diverse 8.9453125
▁groups 1.5693359375
, 1.4365234375
▁the 1.033203125
▁study 2.703125
▁used 1.5849609375
▁multiple 4.7265625
▁log 2.81640625
istic 0.036651611328125
▁regression 0.09735107421875
▁analysis 0.6513671875
▁and 2.55078125
▁chose 8.90625
▁medical 7.421875
▁mar 0.397705078125
iju 0.0021228790283203125
ana 0.0002918243408203125
▁as 0.833984375
▁the 1.12890625
▁control 2.6875
▁group 0.5478515625
. 0.31201171875
<0x0A> 0.74609375
This 3.5
▁type 6.203125
▁of 0.00708770751953125
▁study 1.7236328125
▁is 1.3251953125
▁the 3.4453125
▁most 2.056640625
▁reve 9.3203125
aling 0.00067901611328125
▁and 1.0869140625
▁inclus 6.4375
ive 0.0024585723876953125
, 2.265625
▁as 1.92578125
▁it 0.37109375
▁contains 4.94921875
▁direct 6.33984375
▁responses 5.04296875
▁from 0.830078125
▁a 3.84765625
▁large 0.9033203125
▁number 0.42626953125
▁of 0.00315093994140625
▁participants 1.4599609375
. 0.65087890625
▁All 4.64453125
▁tools 9.0390625
▁in 4.5546875
▁the 0.6640625
▁form 3.529296875
▁of 0.041351318359375
▁question 1.767578125
na 0.036224365234375
ires 9.775161743164062e-05
▁and 2.123046875
▁scales 3.04296875
▁have 3.638671875
▁already 4.421875
▁been 0.1754150390625
▁used 1.9072265625
▁and 2.09375
▁proved 4.23046875
▁their 1.7353515625
▁effic 3.943359375
acy 7.343292236328125e-05
▁for 3.65625
▁collect 4.71484375
ing 0.018463134765625
▁analyt 8.28125
ical 0.2403564453125
▁data 0.272216796875
. 0.4267578125
▁It 3.576171875
▁helps 4.8515625
▁to 0.9375
▁system 7.29296875
at 1.3349609375
ize 0.006023406982421875
▁and 1.587890625
▁class 4.0234375
ify 0.0021724700927734375
▁distinct 9.3046875
▁kinds 6.36328125
▁of 0.024658203125
▁information 3.53125
▁for 3.919921875
▁subsequent 4.03125
▁un 8.0
comp 5.4921875
licated 0.060272216796875
▁services 11.7578125
. 0.64990234375
▁Thus 4.3984375
, 0.02337646484375
▁research 4.48828125
ers 0.54296875
▁can 1.3701171875
▁compare 3.970703125
▁the 0.94580078125
▁effects 3.005859375
▁of 0.10687255859375
▁medic 4.40625
ations 0.89990234375
▁on 1.8076171875
▁patients 2.0703125
▁of 4.48828125
▁diverse 4.0703125
▁age 2.615234375
▁groups 0.6806640625
, 0.923828125
▁background 5.06640625
s 0.2049560546875
, 0.07440185546875
▁physical 5.39453125
▁conditions 1.4267578125
, 0.08856201171875
▁emot 5.54296875
ional 0.060791015625
▁states 1.3984375
, 0.10467529296875
▁and 0.44091796875
▁so 3.1875
▁on 0.33251953125
. 0.09320068359375
<0x0A> 0.64208984375
The 1.0830078125
▁analysis 4.50390625
▁of 0.57421875
▁any 8.984375
▁human 6.12109375
▁reaction 4.91796875
▁has 4.60546875
▁a 1.7451171875
▁high 4.48828125
▁potential 3.4765625
▁of 1.65234375
▁subject 5.99609375
iveness 3.939453125
▁and 1.3388671875
▁bias 2.259765625
, 1.8681640625
▁especially 2.40234375
▁regarding 4.38671875
▁people 4.48828125
▁in 3.931640625
▁se 9.7265625
ere 15.4609375
▁pain 5.6796875
▁and 2.865234375
▁un 5.8984375
stable 2.490234375
▁emot 0.890625
ional 0.219970703125
▁condition 2.5703125
. 0.08123779296875
▁Perhaps 8.9375
▁some 5.01953125
▁patients 2.369140625
▁tend 5.51171875
▁to 0.0269622802734375
▁ex 2.798828125
agger 0.002376556396484375
ate 0.00875091552734375
▁their 0.73486328125
▁de 5.1328125
press 1.4990234375
ive 0.27734375
▁state 2.994140625
▁or 1.888671875
▁vice 7.33984375
▁vers 0.0186920166015625
a 0.0007243156433105469
, 1.04296875
▁de 7.42578125
- 4.7890625
emph 0.92919921875
as 0.00836944580078125
ize 0.1640625
▁serious 6.70703125
▁difficulties 5.79296875
. 0.83935546875
▁Because 6.12109375
▁the 2.314453125
▁survey 6.09765625
▁responses 6.6171875
▁were 1.615234375
▁thoroughly 7.91015625
▁anonymous 5.25
, 0.4599609375
▁the 1.47265625
▁research 1.552734375
ers 0.2666015625
▁were 1.4208984375
▁unable 2.50390625
▁to 0.01345062255859375
▁carefully 8.6875
▁analyze 1.5830078125
▁each 3.966796875
▁patient 2.52734375
’ 26.984375
s 0.90869140625
▁reaction 3.724609375
▁and 2.392578125
▁compare 3.548828125
▁it 0.89990234375
▁to 1.2373046875
▁the 0.75244140625
▁actual 5.671875
▁states 7.27734375
▁of 0.70068359375
▁condition 7.30078125
. 0.368408203125
▁More 6.87890625
▁accurate 3.84765625
▁answers 4.6875
▁could 2.494140625
▁be 0.8994140625
▁obtained 0.970703125
▁by 1.3828125
▁professional 7.48046875
▁psych 2.14453125
olog 0.32763671875
ists 0.00283050537109375
▁via 8.0234375
▁personal 3.9296875
▁communication 4.64453125
▁and 1.8369140625
▁behavior 7.21484375
al 0.342041015625
▁analysis 2.244140625
. 0.2308349609375
▁However 2.70703125
, 0.0030059814453125
▁this 1.9140625
▁method 2.8515625
▁of 2.283203125
▁research 2.166015625
▁is 0.91455078125
▁way 7.9765625
▁more 1.6591796875
▁resource 6.640625
- 0.455078125
int 0.5390625
ensive 0.009185791015625
▁and 0.6201171875
▁energy 8.6953125
- 0.12249755859375
consum 0.31787109375
ing 0.0029544830322265625
. 0.60400390625
<0x0A> 0.64013671875
Part 5.484375
icip 0.08331298828125
ants 0.12939453125
▁were 1.0322265625
▁rec 1.50390625
ru 0.0016918182373046875
ited 0.0004394054412841797
▁for 1.16796875
▁six 1.2890625
▁months 0.0257720947265625
▁at 0.50244140625
▁two 0.130615234375
▁major 0.401123046875
▁pain 0.04241943359375
▁relief 0.0305023193359375
▁cent 0.0303802490234375
ers 0.01134490966796875
▁in 0.07476806640625
▁Israel 0.041229248046875
. 0.1602783203125
▁All 3.4375
▁patients 1.564453125
▁experien 6.84765625
ec 11.6015625
d 5.05078125
▁chron 1.84765625
ic 0.0038852691650390625
▁pain 0.072998046875
▁for 3.361328125
▁at 0.7744140625
▁least 0.0035877227783203125
▁ 1.0400390625
3 1.3896484375
▁months 0.21533203125
. 1.1357421875
▁The 1.4892578125
▁study 1.966796875
▁included 2.0859375
▁ 1.10546875
8 2.943359375
9 2.755859375
0 3.552734375
▁participants 1.537109375
, 1.248046875
▁of 1.8115234375
▁which 0.423828125
▁ 0.146484375
4 1.6103515625
7 2.47265625
4 2.76171875
▁( 2.142578125
5 0.11077880859375
9 11.125
%) 0.962890625
▁were 0.468994140625
▁treated 4.54296875
▁sole 6.9765625
ly 0.0003135204315185547
▁with 0.52587890625
▁op 0.90966796875
io 0.427978515625
ids 0.1983642578125
, 1.169921875
▁ 0.59619140625
3 1.0888671875
2 2.09765625
9 2.556640625
▁( 0.0491943359375
4 1.201171875
1 1.25390625
%) 0.1282958984375
▁were 1.3623046875
▁treated 0.53076171875
▁with 0.213623046875
▁MM 0.85009765625
, 0.297607421875
▁and 0.1624755859375
▁ 0.142333984375
7 3.216796875
7 2.419921875
▁( 0.1861572265625
8 3.859375
. 1.1669921875
6 3.041015625
%) 0.05596923828125
▁acquired 9.4453125
▁both 1.1640625
▁( 7.046875
Fe 10.1640625
ing 3.017578125
old 0.022705078125
▁et 1.416015625
▁al 0.028533935546875
., 0.322021484375
▁ 0.015899658203125
2 0.147705078125
0 0.0006451606750488281
1 0.38232421875
7 2.048828125
). 0.1390380859375
▁The 1.349609375
▁remaining 6.9921875
▁ten 8.2265625
▁participants 1.3671875
▁who 5.4765625
▁did 1.5068359375
▁not 0.01202392578125
▁receive 1.7939453125
▁ph 2.984375
arma 0.063232421875
ce 0.001995086669921875
ut 0.00022482872009277344
ical 0.003925323486328125
▁op 0.9384765625
io 0.0908203125
ids 0.02520751953125
▁and 1.7060546875
▁medical 2.478515625
▁mar 0.050445556640625
iju 0.0151214599609375
ana 0.001102447509765625
▁were 1.3125
▁with 5.9921875
dra 0.177490234375
wn 0.0008540153503417969
▁from 0.27490234375
▁the 0.11419677734375
▁analysis 4.56640625
▁in 4.84765625
▁the 1.16015625
▁research 4.28125
. 0.71337890625
▁Therefore 4.8828125
, 0.00884246826171875
▁it 3.83203125
▁is 0.91650390625
▁not 2.73046875
▁F 14.5703125
possible 10.0
▁to 0.077392578125
▁compreh 6.5625
ens 0.10003662109375
ively 0.040130615234375
▁compare 1.873046875
▁patients 5.015625
▁taking 4.46875
▁medic 3.869140625
ations 0.490234375
▁with 1.037109375
▁those 1.349609375
▁who 1.1689453125
▁do 1.759765625
▁not 0.01343536376953125
. 0.77197265625
<0x0A> 0.59423828125
The 1.1083984375
▁study 1.6962890625
▁conducted 4.74609375
▁a 2.037109375
▁correlation 5.9296875
▁type 7.43359375
▁of 0.478759765625
▁research 1.94921875
▁with 2.83203125
▁variable 7.98828125
▁measures 4.46484375
. 1.2353515625
▁It 2.1328125
▁evaluated 4.40234375
▁the 0.5654296875
▁inter 6.26953125
dep 3.65625
end 0.0027618408203125
ence 0.0177154541015625
▁of 0.5595703125
▁various 3.9140625
▁factors 1.646484375
▁that 2.7734375
▁affected 4.1171875
▁the 0.59033203125
▁physical 6.890625
▁and 0.90625
▁emot 0.5146484375
ional 0.0006413459777832031
▁condition 1.02734375
▁of 0.1055908203125
▁patients 0.619140625
▁experien 3.22265625
cing 0.037994384765625
▁chron 0.5556640625
ic 0.0009069442749023438
▁pain 0.0280914306640625
. 0.2257080078125
▁For 3.822265625
▁example 1.1416015625
, 0.0176239013671875
▁the 1.224609375
▁survey 5.13671875
▁showed 3.400390625
▁that 0.417236328125
▁the 1.7431640625
▁ratio 6.89453125
▁of 0.123046875
▁female 4.31640625
▁patients 0.79443359375
▁was 1.8076171875
▁remark 9.5859375
ably 0.002849578857421875
▁higher 0.5234375
▁in 2.6640625
▁the 0.93017578125
▁op 4.53125
i 3.833984375
ates 0.242431640625
▁group 0.28662109375
▁compared 2.755859375
▁to 0.125
▁the 0.50927734375
▁MM 0.5048828125
▁group 0.309326171875
. 0.480224609375
▁In 2.982421875
▁turn 4.02734375
, 0.00397491455078125
▁people 5.97265625
▁on 5.66796875
▁op 1.453125
i 0.480224609375
ates 0.0069122314453125
▁were 1.03515625
▁more 0.99755859375
▁likely 0.380859375
▁to 0.0672607421875
▁report 3.228515625
▁major 5.9921875
▁de 0.40673828125
press 1.228515625
ive 0.00555419921875
▁dis 0.4794921875
orders 1.3837890625
. 1.7763671875
<0x0A> 2.486328125
The 1.1083984375
▁question 5.73046875
na 1.2109375
ires 0.0007348060607910156
▁used 1.986328125
▁different 8.2265625
▁variable 8.6328125
▁measures 0.80908203125
▁to 1.3671875
▁collect 2.37109375
▁information 1.966796875
. 1.6123046875
▁For 1.9501953125
▁example 0.1961669921875
, 0.0084228515625
▁it 4.0390625
▁included 2.419921875
▁compreh 8.6484375
ensive 0.027801513671875
▁so 6.83203125
cio 0.05035400390625
- 0.479248046875
dem 0.093505859375
ographic 0.042205810546875
▁data 1.0380859375
: 4.875
▁gender 1.6181640625
, 0.0919189453125
▁age 0.214599609375
, 0.08740234375
▁country 4.37109375
, 1.4873046875
▁type 4.3515625
▁of 0.0556640625
▁residence 3.859375
▁( 3.4296875
urban 2.037109375
/ 2.93359375
r 0.06988525390625
ural 0.002368927001953125
), 0.2398681640625
▁years 5.94921875
▁of 0.172607421875
▁education 0.74365234375
, 0.154052734375
▁and 1.841796875
▁employ 3.640625
ment 0.00577545166015625
▁status 0.453369140625
. 0.1806640625
▁Pat 4.0859375
ients 0.10308837890625
▁were 1.216796875
▁also 0.859375
▁asked 0.634765625
▁about 1.158203125
▁their 0.60595703125
▁medical 2.779296875
▁history 0.413330078125
▁over 8.671875
▁the 0.160888671875
▁years 3.80859375
▁and 1.7822265625
▁the 1.8251953125
▁current 3.39453125
▁presence 5.82421875
▁of 0.0548095703125
▁any 2.68359375
▁severe 4.8125
▁dise 1.4697265625
ases 0.0005593299865722656
▁such 4.140625
▁as 0.006656646728515625
▁heart 2.400390625
▁failure 2.015625
, 0.1953125
▁di 1.8662109375
ab 0.0025653839111328125
etes 0.005809783935546875
, 0.1243896484375
▁ar 3.791015625
th 0.1434326171875
rit 0.039031982421875
is 0.015380859375
, 0.046356201171875
▁and 1.5654296875
▁so 0.76806640625
▁on 0.037506103515625
. 0.0474853515625
▁The 1.890625
▁third 7.19140625
▁measure 3.94921875
▁of 2.080078125
▁the 1.015625
▁question 2.916015625
naire 0.19140625
▁was 0.99072265625
▁indicated 9.75
▁by 0.626953125
▁information 6.57421875
▁on 1.5576171875
▁any 5.31640625
▁twelve 13.546875
- 1.158203125
month 0.36279296875
▁and 5.8359375
▁lifetime 3.2109375
▁drug 4.65234375
▁and 3.5546875
▁alco 0.0804443359375
hol 0.00029015541076660156
▁consumption 2.572265625
. 0.45458984375
▁In 3.48046875
▁addition 0.794921875
, 0.12359619140625
▁the 1.1513671875
▁record 7.87890625
▁included 1.71484375
▁a 2.4921875
▁pain 6.40234375
▁measurement 4.31640625
▁scale 1.056640625
▁from 3.615234375
▁ 0.459228515625
0 0.437255859375
▁to 0.432373046875
▁ 0.008209228515625
1 0.09454345703125
0 0.07379150390625
▁to 4.578125
▁evaluate 1.5185546875
▁dis 5.9140625
com 0.1978759765625
fort 0.0030345916748046875
▁feelings 7.28125
▁during 3.33203125
▁the 0.923828125
▁last 1.4609375
▁month 1.59765625
. 0.27685546875
<0x0A> 1.15625
Am 6.8984375
ong 0.0164031982421875
▁all 2.3125
▁participants 2.021484375
▁in 3.525390625
▁the 0.1697998046875
▁study 0.370361328125
, 0.057647705078125
▁ 0.6455078125
4 1.7880859375
2 2.736328125
. 1.7685546875
2 2.302734375
% 0.1497802734375
▁suffered 4.890625
▁from 0.1417236328125
▁de 1.7060546875
pression 0.1632080078125
, 1.0703125
▁and 1.7734375
▁ 0.1480712890625
3 1.728515625
7 2.23046875
% 2.72265625
▁experienced 2.234375
▁excess 7.859375
ive 0.0997314453125
▁anx 0.25634765625
iety 0.00262451171875
. 0.341064453125
▁The 1.4208984375
▁pl 11.1953125
ur 0.9892578125
ality 0.00042700767517089844
▁of 0.2039794921875
▁de 3.521484375
press 1.3203125
ive 0.0304718017578125
▁dis 1.7998046875
orders 0.062255859375
▁among 3.81640625
▁patients 1.201171875
▁in 3.65234375
▁the 0.337646484375
▁op 1.3671875
i 0.92138671875
ates 0.00749969482421875
, 7.11328125
▁medical 3.029296875
▁mar 0.0223236083984375
iju 0.0157928466796875
ana 0.000232696533203125
, 0.1209716796875
▁and 0.064453125
▁mixed 6.078125
▁OP 8.7421875
MM 5.1484375
▁groups 0.475341796875
▁number 8.140625
ed 0.01087188720703125
▁ 0.12164306640625
5 2.20703125
7 2.494140625
. 0.2105712890625
1 2.373046875
%, 0.24462890625
▁ 0.005401611328125
2 3.015625
2 2.439453125
. 0.1021728515625
3 2.2265625
%, 0.1185302734375
a 14.59375
▁ 1.3251953125
nd 2.85546875
▁ 0.035736083984375
5 3.044921875
1 2.615234375
. 0.15966796875
4 2.1796875
%, 0.65576171875
▁respectively 0.045928955078125
. 0.2919921875
▁The 1.462890625
▁pl 4.71484375
ur 0.0271453857421875
ality 0.0001392364501953125
▁of 0.04541015625
▁anx 0.88623046875
iety 0.018157958984375
▁contained 11.125
▁ 0.64013671875
4 1.595703125
8 2.353515625
. 0.06671142578125
4 2.3125
% 0.5380859375
▁among 1.63671875
▁OP 6.1640625
▁patients 8.90625
, 0.24853515625
▁ 0.11883544921875
2 1.4736328125
1 2.40625
. 0.1405029296875
5 2.5
% 0.0185394287109375
▁among 0.48486328125
▁MM 0.360595703125
▁patients 0.279052734375
, 0.01904296875
▁and 0.045654296875
▁ 0.045867919921875
3 1.1728515625
8 2.603515625
. 0.154541015625
7 2.271484375
% 0.0250091552734375
▁among 0.291015625
▁OP 4.02734375
MM 0.2283935546875
▁participants 3.44921875
. 0.2362060546875
▁Pat 5.81640625
ients 0.0230865478515625
▁who 2.40625
▁took 2.9453125
▁strong 8.3046875
▁op 1.173828125
i 1.3583984375
ates 0.00595855712890625
▁were 1.7255859375
▁t 8.7734375
ended 1.310546875
▁to 0.0195465087890625
▁place 10.421875
▁their 3.677734375
▁pain 2.74609375
▁on 3.5
▁a 0.8671875
▁scale 2.365234375
▁of 0.640625
▁ 0.35693359375
9 2.755859375
▁to 1.3447265625
▁ 0.018402099609375
1 0.0228271484375
0 0.083740234375
▁( 2.58203125
Fe 1.7958984375
ing 0.01358795166015625
old 0.00124359130859375
▁et 0.0316162109375
▁al 0.005748748779296875
., 0.01120758056640625
▁ 0.006137847900390625
2 0.0007753372192382812
0 0.0002269744873046875
1 0.0025787353515625
7 0.016265869140625
). 0.056915283203125
▁They 4.69140625
▁were 1.296875
▁also 1.4140625
▁an 8.7421875
gu 4.4765625
ished 0.053802490234375
▁em 8.515625
otion 0.0242156982421875
ally 0.005817413330078125
▁and 1.1630859375
▁react 6.86328125
ed 0.053192138671875
▁rad 9.421875
ically 0.0155487060546875
▁neg 5.3359375
atively 0.00232696533203125
▁to 0.361328125
▁almost 5.2890625
▁all 1.1845703125
▁survey 8.2734375
▁questions 0.63623046875
. 0.2919921875
▁Pat 4.21875
ients 0.0082550048828125
▁who 1.1513671875
▁took 1.5224609375
▁only 5.49609375
▁MM 0.8623046875
▁or 3.208984375
▁mixed 3.4296875
▁medic 2.60546875
ations 0.313720703125
▁course 12.5234375
▁had 2.44921875
▁a 1.2548828125
▁significantly 2.578125
▁more 4.046875
▁stable 3.396484375
▁emot 1.201171875
ional 0.00856781005859375
▁state 0.7900390625
▁and 1.43359375
▁cop 5.59375
ed 0.76416015625
▁with 0.724609375
▁pain 1.5185546875
▁more 1.673828125
▁manage 6.87109375
able 2.3828125
. 0.5078125
<0x0A> 0.69677734375
One 5.1953125
▁of 0.60986328125
▁the 0.0204925537109375
▁major 2.548828125
▁limitations 2.810546875
▁is 3.921875
▁the 0.5263671875
▁ins 4.80859375
u 0.0247650146484375
fficient 0.13134765625
ly 4.70703125
▁high 3.015625
▁response 2.994140625
▁rate 0.1292724609375
, 2.66015625
▁ 4.5390625
5 1.9521484375
7 2.060546875
% 2.119140625
▁instead 7.46484375
▁of 0.0102691650390625
▁ 0.69189453125
7 1.51953125
0 1.4697265625
% 1.1220703125
▁( 1.650390625
Fe 0.2978515625
ing 0.005947113037109375
old 0.0010480880737304688
▁et 0.007251739501953125
▁al 0.00360870361328125
., 0.007312774658203125
▁ 0.005229949951171875
2 0.0006747245788574219
0 6.246566772460938e-05
1 0.0014057159423828125
7 0.00823974609375
). 0.04217529296875
▁It 2.708984375
▁can 3.279296875
▁be 0.433837890625
▁fairly 8.3046875
▁explained 1.546875
▁by 0.19140625
▁the 0.329833984375
▁weak 8.1953125
▁focus 7.109375
▁of 0.462890625
▁respond 6.2421875
ents 0.1370849609375
▁who 3.486328125
▁have 4.06640625
▁overcome 7.97265625
▁severe 2.677734375
▁pain 0.7138671875
▁sens 8.4296875
ations 1.10546875
▁and 1.1962890625
▁de 4.35546875
press 1.7666015625
ive 0.258544921875
▁episodes 3.974609375
. 0.60400390625
▁It 3.38671875
▁is 0.84912109375
▁not 2.650390625
▁clear 4.16015625
▁how 1.6787109375
▁to 3.53125
▁use 5.31640625
▁these 3.0078125
▁statistics 3.412109375
, 2.58203125
▁as 1.41796875
▁they 1.3193359375
▁still 6.05859375
▁may 4.76953125
▁be 1.3212890625
▁relevant 5.3828125
▁for 1.4140625
▁the 1.8427734375
▁overall 4.48046875
▁analysis 3.02734375
. 1.078125
